Browsing Tag
ARIS platform
2 posts
Can bioresorbable drug‑eluting scaffolds solve the compliance problem in chronic sinus care?
Can bioresorbable nasal implants like ARIS and PROPEL improve compliance in chronic sinus care? Explore how this growing tech is reshaping ENT drug delivery.
What makes Aptar Pharma’s latest nasal drug delivery bet a potential market disruptor?
Aptar Pharma teams up with Dianosic to advance a bioresorbable nasal scaffold platform for chronic sinus and rhinitis care. Find out how this could reshape treatment.